Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2023 · 10-Q
Revenue$235.87M$235.87M−39.6% vs Q3 2022 Net Income$23.13M$23.13M−36.0% vs Q3 2022 EPS Diluted$2.12$2.12−35.2% vs Q3 2022 Gross Profit$177,377,000−37.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$29,930,000−46.0% Free Cash Flowderived$28,252,000−47.3% Margins · derivedGross margin75.2%+2.8 pt vs Q3 2022
Operating margin10.8%−1.5 pt vs Q3 2022
Net margin9.8%+0.5 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 6, 2023 · 37 d after period end